Bank of New York Mellon’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $142K | Buy |
61,604
+6,681
| +12% | +$15.4K | ﹤0.01% | 4017 |
|
|
2025
Q1 | $429K | Buy |
54,923
+4,521
| +9% | +$35.3K | ﹤0.01% | 3505 |
|
|
2024
Q4 | $235K | Buy |
50,402
+850
| +2% | +$3.97K | ﹤0.01% | 3867 |
|
|
2024
Q3 | $267K | Sell |
49,552
-9,048
| -15% | -$48.8K | ﹤0.01% | 3811 |
|
|
2024
Q2 | $517K | Buy |
58,600
+32,511
| +125% | +$287K | ﹤0.01% | 3564 |
|
|
2024
Q1 | $307K | Sell |
26,089
-7,311
| -22% | -$85.9K | ﹤0.01% | 3756 |
|
|
2023
Q4 | $376K | Buy |
33,400
+509
| +2% | +$5.73K | ﹤0.01% | 3700 |
|
|
2023
Q3 | $223K | Buy |
+32,891
| New | +$223K | ﹤0.01% | 3918 |
|